Northern District of California Dismisses Intel Securities Fraud Claims With Prejudice

Northern District of California Dismisses Intel Securities Fraud Claims With Prejudice

Joseph Levi Joseph Levi
3 minute read

Caption: In re Intel Corporation Securities Litigation

Case No. 3:24-cv-02683-TLT 

Jurisdiction: U.S.  District Court, Northern District of California 

Judge: Hon. Trina L. Thompson 

Class Period: January 25, 2024 to August 1, 2025

Summary 

On July 23, 2025,Judge Thompson  granted Defendants’ motion to dismiss in In re Intel Corp. Securities Litigation, dismissing all Section 10(b) and 20(a) claims with prejudice. The Court found no material misstatements, scienter, or loss causation in Plaintiffs’ allegations about Intel’s Internal Foundry Model and foundry losses.  Judge Landry denied plaintiffs leave to amend. 

Underlying Lawsuit 

Plaintiffs Intel Investor Group and Byoung Wook Jeon, represented purchasers of Intel common stock, call options, or put options during the Class Period.  Plaintiffs said Intel and some of its executives (CEO Patric Gelsinger and CFO David Zinsner) violated of Section 10(b) of the Securities Exchange Act and SEC Rule 10b-5.   Plaintiffs also alleged Gelsinger and Zinsner violated  Section 20(a) of the Exchange Act. The Second Amended Complaint claimed Defendants misled investors about Intel Foundry’s financials and the Internal Foundry Model’s implementation, obscuring $7 billion in losses until recast results were disclosed in April 2024, causing stock price drops. 

Defendants’ Motion to Dismiss Arguments 

Defendants moved to dismiss under Rule 12(b)(6), arguing: 

Falsity: No GAAP violation, as EY’s clean audit confirmed compliance; statements were forward-looking, puffery, or not misleading. 

Scienter: Insufficient facts showed knowledge or recklessness about foundry losses. 

Loss Causation: Disclosures did not reveal concealed risks; market already knew issues  

Plaintiffs’ Opposition

Plaintiffs said Intel’s FY 2023 financials hid foundry losses by not reporting Internal Foundry results.  They also said Gelsinger and Zinsner’s statements on efficiencies were misleading. Scienter stemmed from executives’ access to P&Ls, and loss causation arose from stock drops post-April 2024 recast disclosures. 

Court’s Ruling

The Court granted the motion, dismissing all claims with prejudice and denying leave to amend, finding amendment wouldn’t solve the complaint’s problems. 

Court’s Rationale 

Falsity 

The Court rejected Plaintiffs’ GAAP violation claim, citing EY’s clean audit, lack of restatement, and insufficient facts showing Gelsinger regularly reviewed Internal Foundry P&Ls for resource allocation. Statements on efficiencies and prospects were puffery or forward-looking, not actionable. 

Scienter 

Plaintiffs failed to plead a strong inference of scienter, as allegations of executives’ knowledge were conclusory and unsupported by particularized facts. 

Loss Causation 

Disclosures did not reveal concealed risks, as the market was aware of foundry challenges; stock drops were not tied to fraud revelations. 

Final Disposition and Next Steps 

All claims are dismissed with prejudice. The Clerk is directed to terminate the case. No further filings or deadlines apply.  

Author 

Joseph Levi is a Managing Partner renowned for his expertise in securities litigation, specifically protecting shareholder rights in securities fraud cases. With extensive courtroom experience, he has secured notable victories, including a $35 million settlement for Occam Networks shareholders and significant relief in fiduciary litigation involving Health Grades. Additionally, Mr. Levi has effectively represented patent holders in high-stakes litigation across technology sectors, including software and communications, achieving substantial settlements and awards. 

LinkedIN

« Back to Blog